ARTICLE | Company News
FDA approves linagliptin/metformin
February 1, 2012 1:29 AM UTC
Boehringer Ingelheim GmbH (Ingelheim, Germany) and partner Eli Lilly and Co. (NYSE:LLY) said FDA approved Jentadueto linagliptin/metformin to treat Type II diabetes. The partners plan to launch the pr...